Hjem › Leverkreft (hepatocellulært karcinom) › Texas › San Antonio
Kliniske studier for Leverkreft (hepatocellulært karcinom) i San Antonio, TX
13 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i og rundt San Antonio (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekruttererFase 1
- START San Antonio, San Antonio
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RekruttererFase 3
- Research Site, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekruttererFase 1
- START San Antonio, San Antonio
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RekruttererFase 1
- START-San Antonio, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
RekruttererFase 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekruttererFase 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekruttererFase 1
- Clinical Trial Site, San Antonio
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RekruttererFase 1/2
- University of Texas Health Science Center - San Antonio, San Antonio
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
RekruttererObservasjonsstudie
- Mays Cancer Center, San Antonio
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
RekruttererFase 2
- UT Health San Antonio, San Antonio
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
RekruttererFase 2
- Mays Cancer Center, UT Health San Antonio, San Antonio
Leverkreft (hepatocellulært karcinom)-studier i andre byer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
Andre studier i San Antonio
- Ikke-småcellet lungekreft59 studier
- Brystkreft47 studier
- Kolorektal kreft46 studier
- Metastatisk kreft44 studier
- Kreft (alle typer)41 studier
- Fedme40 studier
- Type 2-diabetes37 studier
- Overvekt34 studier
- Eggstokkreft31 studier
- Pankreaskreft31 studier
- Prostatakreft28 studier
- Endometriekreft27 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.